Cardiovascular magnetic resonance in adults with previous cardiovascular surgery

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 3, 2014, Pages 235-248

  Von Knobelsdorff Brenkenhoff, Florian ^a,b   Trauzeddel, Ralf Felix ^a,b   Schulz Menger, Jeanette ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

aorta; cardiovascular surgery; coronary bypass; magnetic resonance; valve replacement

Indexed keywords

CONTRAST MEDIUM; DOBUTAMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANGIOCARDIOGRAPHY; AORTA SURGERY; ASCENDING AORTA; ASCENDING AORTA SURGERY; BLOOD FLOW VELOCITY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SURGERY; CONGENITAL HEART DISEASE; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; HEART MUSCLE PERFUSION; HEART VALVE PROSTHESIS; HEART VALVE REGURGITATION; HEART VALVE SURGERY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MECHANICAL HEART VALVE; PATIENT SAFETY; PERICARDIUM; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROSTHETIC VALVE ENDOCARDITIS; PROSTHETIC VALVE THROMBOSIS; REVIEW; ROSS PROCEDURE;

AORTA; CARDIOVASCULAR SURGERY; CORONARY BYPASS; MAGNETIC RESONANCE; VALVE REPLACEMENT;

ADULT; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; SENSITIVITY AND SPECIFICITY;

EID: 84896716029     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jet138     Document Type: Review

References (53)

1. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: society for cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. J CardiovascMagn Reson 2013; 15:35.
2. Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC et al. ACCF/ACR/ SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American college of cardiology foundation quality strategic directions committee appropriateness criteria working group, American college of radiology, society of cardiovascular computed tomography, society for cardiovascular magnetic resonance, American society of nuclear cardiology, North American society for cardiac imaging, society for cardiovascular angiography and interventions, and society of interventional radiology. J Am Coll Cardiol 2006;48:1475-97.
3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart J 2012;33:2451-96.
4. Levine GN, Gomes AS, Arai AE, BluemkeDA, Flamm SD, Kanal E et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American heart association scientific statement fromthe committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology, and the council on cardiovascular radiology and intervention: endorsed by the American college of cardiology foundation, the north American society for cardiac imaging, and the society for cardiovascular magnetic resonance. Circulation 2007;116:2878-91.
5. von Knobelsdorff-Brenkenhoff F, Rudolph A,Wassmuth R, Bohl S, Buschmann EE, Abdel-Aty H et al. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. Circ Cardiovasc Imaging 2009;2:397-404.
6. Shellock FG. Reference Manual forMagnetic Resonance Safety, Implants and Devices. Los Angeles: Biomedical Research Publishing Group; 2011.
7. Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-46.
8. Shinbane JS, Colletti PM, Shellock FG. Magnetic resonance imaging in patients with cardiac pacemakers: Era of "MR conditional" designs. J Cardiovasc Magn Reson 2011;13:63.
9. von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance imaging in ischemic heart disease. J Magn Reson Imaging 2012;36:20-38.
10. Nandalur KR,DwamenaBA, Choudhri AF, Nandalur MR,Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-Analysis. J Am Coll Cardiol 2007;50:1343-53.
11. Kelle S, Graf K, Dreysse S, Schnackenburg B, Fleck E, Klein C. Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion CMR in patients post bypass surgery. J Cardiovasc Magn Reson 2010;12:28.
12. Arnold JR, Francis JM, KaramitsosTD, Lim CC, van Gaal WJ, Testa L et al. Myocardial perfusion imaging after coronary artery bypass surgery using cardiovascular magnetic resonance: a validation study. Circ Cardiovasc Imaging 2011;4:312-8.
13. Bernhardt P, Spiess J, Levenson B, Pilz G, Hofling B, Hombach V et al. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol. JACC Cardiovasc Imaging 2009;2:1292-300.
14. Klein C, Nagel E, Gebker R, Kelle S, Schnackenburg B, Graf K et al. Magnetic resonance adenosine perfusion imaging in patients after coronary artery bypass graft surgery. JACC Cardiovasc Imaging 2009;2:437-45.
15. Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, KitzmanDW et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999;100:1697-702.
16. Langerak SE, Vliegen HW, de Roos A, Zwinderman AH, Jukema JW, Kunz P et al. Detection of vein graft disease using high-resolution magnetic resonance angiography. Circulation 2002;105:328-33.
17. Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-76.
18. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol 2010;56:1225-34.
19. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
20. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
21. Lim CC, Cuculi F, van Gaal WJ, Testa L, Arnold JR, Karamitsos T et al. Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: a study using biomarkers and cardiac magnetic resonance imaging. Ann Thorac Surg 2011;92: 2046-53.
22. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43.
23. Rahimi K, Banning AP, Cheng AS, Pegg TJ, Karamitsos TD, Channon KM et al. Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart 2009;95:1937-43.
24. Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:7.
25. ZoghbiWA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American society of echocardiographys guidelines and standards committee and the task force on prosthetic valves, developed in conjunction with the American college of cardiology cardiovascular imaging committee, cardiac imaging committee of the American heart association, the European association of echocardiography, a registered branch of the European society of cardiology, the Japanese society of echocardiography and the Canadian society of echocardiography, endorsed by the American college of cardiology foundation, American heart association, European association of echocardiography, a registered branch of the European society of cardiology, the Japanese society of echocardiography, and Canadian society of echocardiography. J Am Soc Echocardiogr 2009;22: 975-1014; quiz 1082-14.
26. Defrance C, Bollache E, Kachenoura N, Perdrix L, Hrynchyshyn N, Bruguiere E et al. Evaluation of aortic valve stenosis using cardiovascular magnetic resonance: comparison of an original semiautomated analysis of phase-contrast cardiovascular magnetic resonance with Doppler echocardiography. Circ Cardiovasc Imaging 2012;5: 604-12.
27. Friedrich MG, Schulz-Menger J, Poetsch T, Pilz B, Uhlich F, Dietz R. Quantification of valvular aortic stenosis by magnetic resonance imaging. Am Heart J 2002;144: 329-34.
28. von Knobelsdorff-Brenkenhoff F, Rudolph A,Wassmuth R, Schulz-Menger J. Assessment of mitral bioprostheses using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:36.
29. von Knobelsdorff-Brenkenhoff F, Dieringer MA, Greiser A, Schulz-Menger J. In vitro assessment of heart valve bioprostheses by cardiovascular magnetic resonance: four-dimensional mapping of flow patterns and orifice area planimetry. Eur J Cardiothorac Surg 2011;40:736-42.
30. Botzenhardt F, Eichinger WB, Bleiziffer S, Guenzinger R, Wagner IM, Bauernschmitt R et al. Hemodynamic comparison of bioprostheses for complete supra-Annular position in patients with small aortic annulus. J Am Coll Cardiol 2005; 45:2054-60.
31. Daneshvar SA, Rahimtoola SH. Valve prosthesis-patient mismatch: a long-termperspective. J Am Coll Cardiol 2012;60:1123-35.
32. von Knobelsdorff-Brenkenhoff F, Rottgen R, Schulz-Menger J. Complementary assessment of aortic bioprosthetic dysfunction using cardiac magnetic resonance imaging and computed tomography. J Heart Valve Dis 2012;21:20-2.
33. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. 2008 Focused update incorporated into the acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/ American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 2008;52:e1-142.
34. Gabriel RS, Renapurkar R, Bolen MA, Verhaert D, Leiber M, Flamm SD et al. Comparison of severity of aortic regurgitation by cardiovascular magnetic resonance versus transthoracic echocardiography. Am J Cardiol 2011;108:1014-20.
35. Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging 2013;6:48-57.
36. Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation 2013;127:397-407.
37. Sherif MA, Abdel-Wahab M, Beurich HW, Stocker B, Zachow D, Geist V et al. Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. Eurointervention 2011;7: 57-63.
38. Stulak JM, BurkhartHM, SundtTMIII,ConnollyHM, SuriRM,SchaffHVet al. Spectrum and outcomeof reoperations after the Ross procedure. Circulation 2010;122:1153-8.
39. Puranik R, Tsang VT, Broadley A, Nordmeyer J, Lurz P, Muthialu N et al. Functional outcomes after the Ross (pulmonary autograft) procedure assessed with magnetic resonance imaging and cardiopulmonary exercise testing. Heart 2010;96:304-8.
40. Grotenhuis HB, de Roos A, Ottenkamp J, Schoof PH, Vliegen HW, Kroft LJ. MR imaging of right ventricular function after the Ross procedure for aortic valve replacement: initial experience. Radiology 2008;246:394-400.
41. Kilner PJ, Geva T, Kaemmerer H, Trindade PT, Schwitter J,Webb GD. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European society of cardiology. Eur Heart J 2010;31:794-805.
42. von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, Abdel-Aty H, Schulz-Menger J. Aortic dilatation in patients with prosthetic aortic valve: comparison of MRI and echocardiography. J Heart Valve Dis 2010;19:349-56.
43. Krishnam MS, Tomasian A, Malik S, Desphande V, Laub G, Ruehm SG. Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases. Eur Radiol 2010;20:1311-20.
44. EichingerWB, Botzenhardt F,Gunzinger R, Kemkes BM, Bleese N, SosnowskiAet al. Left ventricular mass regression after aortic valve replacement with the mosaic bioprosthesis. J Heart Valve Dis 2002;11:529-36.
45. von Knobelsdorff-Brenkenhoff F, Buschmann EE, Pilz B, Schulz-Menger J. Persistent Cabrol shunt causing severe right heart failure. Ann Thorac Surg 2010;90:312.
46. Subramanian S, Borger MA. Aortic valve reconstruction: current status. Herz 2010; 35:88-93.
47. Markl M, DraneyMT, MillerDC, Levin JM, Williamson EE, PelcNJ et al. Time-resolved three-dimensional magnetic resonance velocity mapping of aortic flow in healthy volunteers and patients after valve-sparing aortic root replacement. J Thorac Cardiovasc Surg 2005;130:456-63.
48. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.
49. Dor V, Civaia F, Alexandrescu C, Montiglio F. The post-myocardial infarction scarred ventricle and congestive heart failure: the preeminence of magnetic resonance imaging for preoperative, intraoperative, and postoperative assessment. J Thorac Cardiovasc Surg 2008;136:1405-12.
50. Gersh BJ,Maron BJ,Bonow RO,Dearani JA, Fifer MA, Link MS et al. 2011ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology foundation/ American heart association task force on practice guidelines. Circulation 2011;124: 2761-96.
51. Schulz-Menger J, Strohm O,Waigand J, Uhlich F, Dietz R, Friedrich MG. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 2000;101:1764-6.
52. Beroukhim RS, Prakash A, Buechel ER, Cava JR, Dorfman AL, Festa P et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol 2011;58:1044-54.
53. Yared K, Baggish AL, Picard MH, Hoffmann U, Hung J. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging 2010;3:650-60.